Economic Times | GSK taps UK firm for 'beyond antibodies' drug technology WKZO GSK taps UK firm for 'beyond antibodies' drug technology. Tuesday, July 09, 2013 7:51 p.m. EDT. By P.J. Huffstutter. LONDON (Reuters) - GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop ... Cutting Edge Cancer Therapy From Immunocore Receives $212M In Funding ... |
